| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/26/2004 | WO2003057822A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003040144A3 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 02/26/2004 | WO2003038058A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 02/26/2004 | WO2003029412A3 Restricted expression lentivial vectors |
| 02/26/2004 | WO2003026568A3 Androstanes as androgen receptor modulators |
| 02/26/2004 | WO2003016472A9 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003006425A9 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/26/2004 | WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 02/26/2004 | WO2002098424B1 Novel anti-infectives |
| 02/26/2004 | WO2002094322A3 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 02/26/2004 | WO2002072636A8 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 02/26/2004 | WO2002051237A3 Helicobacter proteins, nucleic acids and uses thereof |
| 02/26/2004 | WO2002046418A3 Lipid-associated molecules |
| 02/26/2004 | WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | WO2002022112A3 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040039197 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals |
| 02/26/2004 | US20040039196 (2-Oxindol-3-ylidenyl) acetic acid derivatives and their use as protein kinase inhibitors |
| 02/26/2004 | US20040039066 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1 |
| 02/26/2004 | US20040039061 Suppress expression and induction of inflammatory cytokines, cell adhesion molecule gene and virus and suppressors for nuclear factor kappa beta (nf-kb) |
| 02/26/2004 | US20040039058 Identifying a mammal having elevated concentrations of tumor necrosis factor- alpha and administering stearidonic acid (18:4, n-3) over a time period |
| 02/26/2004 | US20040039056 9-cis retinoic acid, pharmaceutically acceptable salts and hydrolyzable esters, prodrugs and metabolites thereof |
| 02/26/2004 | US20040039040 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 02/26/2004 | US20040039038 Biaromatic compound activators of PPARy-type receptors |
| 02/26/2004 | US20040039011 Administering anticholinergic or bronchodilator agents such as tiotropium bromide for prophylaxis of respiratory system disorders |
| 02/26/2004 | US20040039007 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 02/26/2004 | US20040039004 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 02/26/2004 | US20040039002 6,7-Dimethoxyquinazolines and therapeutic use thereof |
| 02/26/2004 | US20040038992 2-thio-(or oxy)-5-amino-1,3,4-thiadiazoles or oxadiazoles |
| 02/26/2004 | US20040038979 Novel 6-heteroarylphenanthridines |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038958 Topical treatment of skin diseases |
| 02/26/2004 | US20040038954 Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 02/26/2004 | US20040038949 Inhibitors of the enzyme CYP24; useful for treating cell-proliferative disorders and for promoting cell differentiation. |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038920 Which stimulate lymphoctyes specific for myelin basic protein (MBP) autoantigen, which induces severe experimental autoimmune encephalomyelitis in animal models; cytokines |
| 02/26/2004 | US20040038889 Fumaric acid amides |
| 02/26/2004 | US20040038887 Copolymers for suppression of autoimmune diseases, and methods of use |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038882 Sgk2 and sgk3 used as diagnostic and therapeutic targets |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038873 Used for the manufacture of medicine for the treatment of developmental disorders, diseases caused by abnormal metabolism of immune system, and cancers |
| 02/26/2004 | US20040038869 Inhibitors of complement activation, their preparation and use |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038293 Antibodies to human cd154 |
| 02/26/2004 | US20040038278 Methods and compositions relating to gene silencing |
| 02/26/2004 | US20040038252 Method of testing for allergic diseases |
| 02/26/2004 | US20040038247 Expression vector comprised of regulatory sequences for lymphocyte specific expression of heterologous polypeptides |
| 02/26/2004 | US20040038238 Comprises chimeric membrane proteins for diagnosis, treatment and prevention of inflammation, cancer, metabolic, gastrointestinal and autoimmune disorders |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040037844 Vaccine |
| 02/26/2004 | US20040037827 Administering antibody to integrin |
| 02/26/2004 | US20040037808 Methods for modulating T cell responses by manipulating a commom cytokine receptor gamma-chain |
| 02/26/2004 | DE20318634U1 Topical compositions for preventing or treating rhinitis, comprising sympathomimetic agent with vasoconstrictive and/or mucosal swelling reducing action and glycosaminoglycan to reduce side-effects |
| 02/26/2004 | DE10231655A1 Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 02/26/2004 | CA2496419A1 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | CA2495511A1 Use of and some novel imidazopyridines |
| 02/26/2004 | CA2495492A1 Novel use of benzothiazole derivatives |
| 02/26/2004 | CA2495406A1 A method of immunomodulation using anti-cd83 antibodies |
| 02/25/2004 | EP1391729A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
| 02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
| 02/25/2004 | EP1391464A1 Anti-cd40 monoclonal antibody |
| 02/25/2004 | EP1391461A1 Bicyclic lactam inhibitors of interleukin-1-beta converting enzyme |
| 02/25/2004 | EP1391457A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors |
| 02/25/2004 | EP1391426A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 02/25/2004 | EP1391221A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 02/25/2004 | EP1391210A2 Regulatory medicament comprising CD4+CD25- T cells and Tr1-like regulatory cells |
| 02/25/2004 | EP1390740A1 Methods and formulations for increasing the affinity of a 1? adenosine receptor ligands for the a 1? adenosine receptor |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390502A2 Interferon-alpha induced gene |
| 02/25/2004 | EP1390478A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 02/25/2004 | EP1390474A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390393A2 Pentapeptide compounds and uses related thereto |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390378A1 Pharmaceutically active uridine esters |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | EP1390348A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors |
| 02/25/2004 | EP1390345A1 Polythiourea lipid derivatives |
| 02/25/2004 | EP1390081A2 Therapeutic and diagnostic compounds, compositions, and methods |
| 02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
| 02/25/2004 | EP1390071A2 Symbiotic regenerative agent |
| 02/25/2004 | EP1390068A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists |
| 02/25/2004 | EP1390067A1 Compositions for use in treating ige-associated disorders |
| 02/25/2004 | EP1390062A2 Modulators of elastase inhibitor secretion |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |